Please login to the form below
GIST
This page shows the latest GIST news and features for those working in and with pharma, biotech and healthcare.
FDA clears Blueprint’s $32k-per-month GI cancer drug
Around 5, 000 people in the US are diagnosed with GIST per year. ... treated GIST patients, extending progression-free survival to six months from one month with placebo.
Latest news
-
AstraZeneca launches $1bn Chinese investment fund
AZ has bolstered its oncology pipeline with a KIT inhibitor for gastrointestinal stromal tumours (GIST) from Ningbo Tai King Medical Technology – now called AZD3229 – and an ERK 1/2 inhibitor for
-
Novartis to buy French radiopharma specialist AAA for $3.9bn
Among AAA’s clinical candidates is 177Lu-NeoBOMB1, a radiopharmaceutical for prostate cancer, gastrointestinal stromal tumours (GIST) and breast cancer.
-
NICE backs Pfizer’s Xeljanz for RA
Meanwhile, NICE has decided to remove Bayer’s gastrointestinal stomach tumour (GIST) treatment Stivarga (regorafenib) from the cancer drugs fund (CDF) to make it routinely available to some patients on the
-
EMA clears Bayer's Stivarga for liver cancer
The green light is a big boost for the product which has been wrestling with tough competition in one of its other approved indications - colorectal cancer and gastrointestinal stromal tumours (GIST) -
-
FDA OK for Stivarga ends decade-long drought in liver cancer
line therapy for gastrointestinal stromal tumours (GIST) a year later, and the new approval will be a big help towards Bayer's ambition to develop the drug into a 1bn-plus
More from news
Approximately 3 fully matching, plus 44 partially matching documents found.
Latest Intelligence
-
Deal Watch November 2016
stromal tumours (GIST).
-
Interview: Harvey Berger and Timothy Clackson, Ariad
for other cancers, such as gastrointestinal stromal tumours (GIST).
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest appointments
-
Kiadis Pharma appoints new chief operations officer
Prior to his time at Janssen, Feijen held positions for the likes of Crucell, Avebe and Gist Brocades.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
An agency called Owen
Of course there’s more to say. But that’s the gist of it.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- bluebird bio reveals plans to launch two gene therapies
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- Eli Lilly to make bebtelovimab commercially available to US states from August
- Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV
- The patient voice – the value of patient-reported outcomes in HTA
- Biogen and Eisai share latest lecanemab results for the treatment of Alzheimer's disease
- Strategic commitment
- Pfizer set to acquire Global Blood Therapeutics in deal worth $5.4bn
- AstraZeneca and Daiichi Sankyo get FDA approval for breast cancer drug
- NHS England launches hepatitis C screening scheme to reach 2030 elimination goal
- Bayer’s Nubeqa receives FDA approval to treat metastatic prostate cancer
- Valneva and Pfizer initiate phase 3 Lyme disease vaccine study
- GSK’s ViiV and Medicines Patent Pool agree deal for HIV prevention
- GSK/Merck KGgA cancer drug fails in third trial
- Chiesi Group's Trimbow wins European licence
- Roche shares new positive Ocrevus data for MS patients
- Roche’s Tecentriq demonstrates positive phase 3 results as a subcutaneous injection
- Using behavioural psychology to improve patient recruitment
PMHub
3 Monkeys Zeno
3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...
Latest intelligence
- Strategic commitment
- ...
- KOL Ambassador Program & Podcast Creation: A Customer Story
- ...
- Animation: Living With
- The journey from the patient's perspective...
